Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
WiDr |
Human colorectal adenocarcinoma cell line | ATCC CCL-218 | Human | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | P. Suboj et al., Pharmacology, 2012, 89: 91–98, DOI: 10.1159/000335659 | ||
tsa201 |
Human embryonic kidney cell line | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | S. Geisler et al., J. of Neuroscience, 2019, 39(14): 2581–2605, 2581, doi.org/10.1523/JNEUROSCI.2234-18.2019 | Link | ||
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | application note | ![]() |
||
PC-6 |
Human small cell lung carcinoma | Human | respiratory system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | D. Safiulina et al., The EMBO J., 2018, e99384, DOI 10.15252/embj.201899384 | Link | ||
NCI H1299 |
Human lung carcinoma cell line | ATCC CRL-5803 | Human | respiratory system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | W. Huang, PhD Thesis, 2014, Indiana University | Link | |
NCI H1299 |
Human lung carcinoma cell line | ATCC CRL-5803 | Human | respiratory system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | S. W. Yang, PhD Thesis, 2014, Seoul National University | Link | |
LoVo |
Human colon adenocarcinoma cell line | ATCC CCL-229 | Human | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | L. M. Williams, Dissertation, 2014, Royal College of Surgeons in Ireland | Link | |
LNcaP |
Human prostate carcinoma cell line | ATCC CRL-1740 | Human | genital tract | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | G. Loubeau et al., PLoS ONE, 2014, 9(5): e96293, doi:10.1371/journal.pone.0096293 | Link | |
K562 |
Human myelogenous leukemia cell line | ATCC CCL-243 | Human | immune system | cell line | suspension | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | O. N. Kuvardina et al., Oncotarget, 2017, 8 (42): 71685-71698 | Link | |
K562 |
Human myelogenous leukemia cell line | ATCC CCL-243 | Human | immune system | cell line | suspension | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | N. Sahner, Dissertation, 2019, Technische Universität Darmstadt | Link | |
JEG-3 |
Human placenta choriocarcinoma cell line | ATCC HTB-36 | Human | respiratory system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | M.-J. Stahnke et al., Cellular Signalling, 2014, 26 :1792-1799doi.org/10.1016/j.cellsig.2014.04.006 | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | S. Thakker et al., Oncotarget, 2018, 9 (1): 1210-1228 | Link | |
HT-29 |
Human colorectal adenocarcinoma cell line | ATCC HTB-38 | Human | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | Y.-L. Wang et al., World J. Gastroenterol., 2014, 20(47): 17924-17931, DOI: 10.3748/wjg.v20.i47.17924 | Link | |
HT-29 |
Human colorectal adenocarcinoma cell line | ATCC HTB-38 | Human | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | L. M. Williams, Dissertation, 2014, Royal College of Surgeons in Ireland | Link | |
HKe-3 |
Human colon carcinoma cell line | Human | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | L. M. Williams, Dissertation, 2014, Royal College of Surgeons in Ireland | Link | ||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | M.-H. Tai et al., Mol. Nutr. Food Res., 2014, 58: 2133-2145 DOI 10.1002/mnfr.201400366 | ||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | A. Raturi et al., J. Cell Biol., Aug 2016; 214, 433 - 444 | ||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | J. Schulz et al., Scientific Reports, 2018, 8: 2395, DOI:10.1038/s41598-018-19201-8 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | K. Wethmar et al., Oncogene, 2016, 35,1736-1742; doi:10.1038/onc.2015.233 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | V. Pfaumann et al., Cellular Microbiology, (2015, 17(4): 579-594; doi:10.1111/cmi.12386 | Link | |
HEK293-rB95.8 |
Human embryonic kidney cell line (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | J. Rac et al., PLoS ONE, 2015, 10(4): e0123645; doi:10.1371/journal.pone.0123645 | Link | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | O. N. Kuvardina et al., Oncotarget, 2017, 8 (42): 71685-71698 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | Z. Li et al., Nature Microbiology, 2019 , 4: 2475–2486, doi.org/10.1038/s41564-019-0546-y | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | A. Dominguez-Meijide et al., Neurobiology of Disease, 2021, 151: 105256, doi.org/10.1016/j.nbd.2021.105256 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | X. Lin et al., PLoS Pathog, 2015, 11(12): e1005344. doi:10.1371/journal.ppat.1005344 | Link |